Rossari Biotech

699.35
-5.25
(-0.75%)
Market Cap
3,871.90 Cr
EPS
23.67
PE Ratio
28.67
Dividend Yield
0.07 %
Industry
Chemicals
52 Week High
972.70
52 Week Low
569.00
PB Ratio
3.49
Debt to Equity
0.10
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from5 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+80.00 %
+80.00 %
Hold
Hold+20.00 %
+20.00 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
neutral
Rossari Biotech Reports Q4 EBITDA Growth1 day ago
Rossari Biotech's Q4 EBITDA increased to 695 million rupees from 636 million rupees year-over-year. However, the EBITDA margin decreased to 11.99% from 13.45% in the same period.
positive
Rossari Biotech Reports Q4 FY2023 Financial Results1 day ago
Rossari Biotech announced its Q4 financial results. The company's consolidated net profit for Q4 was 344 million rupees, showing a slight increase from 341 million rupees year-over-year (YoY) and a more significant increase from 317 million rupees quarter-over-quarter (QoQ). Revenue for Q4 stood at 5.8 billion rupees, up from 4.73 billion rupees in the same quarter last year, indicating substantial growth.
positive
Rossari Biotech Units Announce Capacity Expansion Plans2 days ago
Rossari Biotech's subsidiaries, Unitop and Tristar, have announced significant capacity expansion plans. Unitop will increase its capacity by 18,500 MTPA in phases until Q4 FY26, with a capital expenditure of ₹77 crore. Tristar will add 3,600 MTPA to its current capacity of 15,000 MTPA, which is currently 90% utilized, investing ₹20 crore in the expansion.
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
3,011.20
#1 1,53,163.95
78.03
12,522.60
#1 5.69
#1 1,747
9.04
62.30
2,968.10
87,981.85
78.53
13,221.50
-11.53
1,336
6.99
52.94
3,977.90
43,697.23
95.45
4,387.70
-25.09
435
57.50
58.34
1,961.30
26,750.77
39.50
7,757.90
-3.26
811
-51.46
47.73
455.70
22,497.05
41.47
4,227.40
0.66
411
34.98
53.14
4,448.70
22,053.77
81.70
2,120.90
0.37
271
7.18
66.73
4,524.90
19,586.32
#1 33.14
#1 13,843.30
-
563
-26.05
50.32
6,414.50
18,349.60
44.13
4,783.90
-13.69
324
#1 121.26
66.88
1,697.60
17,598.28
46.01
1,938.80
-8.77
323
21.85
63.96
428.95
15,550.29
43.95
6,380.70
-3.61
417
-62.90
59.23
Growth Rate
Revenue Growth
10.63 %
Net Income Growth
21.81 %
Cash Flow Change
-71.46 %
ROE
6.40 %
ROCE
5.08 %
EBITDA Margin (Avg.)
1.75 %

Quarterly Financial Results

Quarterly Financials
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
129
151
163
162
112
176
211
220
234
387
434
442
436
426
390
410
413
485
467
473
491
499
514
582
Expenses
106
122
133
136
86
142
176
182
194
339
381
387
377
369
335
352
353
420
400
409
425
432
448
510
EBITDA
23
29
30
26
26
34
35
38
40
48
53
56
59
58
55
58
60
65
67
64
66
67
66
71
Operating Profit %
17 %
19 %
18 %
15 %
22 %
18 %
16 %
17 %
16 %
12 %
11 %
12 %
13 %
13 %
14 %
13 %
14 %
13 %
14 %
13 %
13 %
13 %
13 %
12 %
Depreciation
4
4
4
5
4
6
6
7
6
10
16
17
15
16
16
16
14
15
15
16
15
15
18
18
Interest
1
1
1
1
1
1
0
1
1
2
5
5
5
8
5
4
6
5
4
3
4
4
5
6
Profit Before Tax
19
24
25
20
21
28
28
30
33
36
33
34
39
34
35
37
40
45
48
46
47
48
42
48
Tax
5
6
6
5
5
7
7
8
9
10
10
10
10
10
9
8
10
12
13
11
12
13
11
13
Net Profit
14
18
18
15
16
21
22
22
25
26
23
24
29
24
26
29
29
33
34
34
35
35
32
34
EPS in ₹
2.93
3.66
3.77
3.11
3.19
4.07
4.16
4.32
4.52
4.77
4.09
4.37
5.21
4.34
4.66
5.25
5.30
5.97
6.23
6.18
6.32
6.39
5.73
6.22

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
Total Assets
250
472
561
1,257
1,368
1,572
Fixed Assets
74
94
181
607
585
578
Current Assets
160
326
355
609
720
844
Capital Work in Progress
3
22
0
1
16
47
Investments
0
18
0
36
51
63
Other Assets
173
338
380
612
715
885
Total Liabilities
250
472
561
1,257
1,368
1,572
Current Liabilities
122
149
150
295
349
425
Non Current Liabilities
4
36
2
157
104
100
Total Equity
124
287
409
805
915
1,048
Reserve & Surplus
119
277
398
794
904
1,037
Share Capital
4
10
10
11
11
11

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
Net Cash Flow
5
24
-14
22
32
-44
Investing Activities
-37
-190
-37
-299
-181
-104
Operating Activities
71
57
48
29
152
43
Financing Activities
-29
157
-25
292
61
16

Share Holding

% Holding
Mar 2021
Apr 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
72.69 %
68.70 %
68.70 %
68.56 %
68.56 %
68.56 %
68.56 %
68.46 %
68.44 %
68.43 %
68.43 %
68.35 %
68.33 %
68.32 %
68.32 %
68.27 %
68.19 %
68.18 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
4.03 %
3.83 %
3.74 %
3.74 %
3.98 %
DIIs
11.26 %
12.53 %
12.32 %
12.62 %
12.52 %
12.13 %
12.86 %
14.02 %
14.08 %
15.09 %
17.71 %
17.68 %
18.02 %
17.75 %
16.87 %
17.34 %
17.47 %
17.59 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
3.69 %
4.20 %
4.75 %
5.00 %
5.17 %
6.05 %
6.44 %
6.53 %
6.97 %
7.15 %
7.14 %
7.53 %
8.76 %
9.14 %
9.96 %
9.57 %
9.51 %
9.20 %
Others
12.36 %
14.57 %
14.23 %
13.82 %
13.75 %
13.27 %
12.15 %
10.99 %
10.51 %
9.33 %
6.72 %
6.45 %
4.89 %
0.76 %
1.02 %
1.09 %
1.09 %
1.05 %
No of Share Holders
0
40,105
40,671
49,324
65,831
76,494
92,099
98,565
95,664
97,081
95,371
95,200
1,00,423
98,859
1,00,475
97,188
95,735
92,852

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.5 0.5 0.5 0.5 0.5 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.05 0.05 0.08 0.07 0.08 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication14 hours ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release15 hours ago
Announcement under Regulation 30 (LODR)-Investor Presentation15 hours ago
Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 1 day ago
Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20151 day ago
Intimation Of Grant Of Options Under Rossari Employee Stock Option Plan- 20191 day ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS1 day ago
Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31 2025.1 day ago
Corporate Action-Board approves Dividend1 day ago
Board Meeting Outcome for Outcome Of Board Meeting Held On April 25 2025.1 day ago
Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20152 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation4 days ago
Intimation Of Change Of Communications Details Of Registrar And Share Transfer Agent8 days ago
Board Meeting Intimation for Board Meeting Intimation For Audited Financial Statements And Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31 2025 And Recommendation Of Final Dividend If Any.9 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderFeb 20, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderFeb 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 03, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJan 31, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 28, 2025
Integrated Filing (Financial)Jan 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 22, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 22, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 22, 2025
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressJan 21, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 21, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On January 21 2025Jan 21, 2025
Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2024.Jan 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 16, 2025
Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2024Jan 13, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Intimation Of Change In The Name Of Registrar And Transfer Agent.Dec 31, 2024
Closure of Trading WindowDec 27, 2024
Announcement under Regulation 30 (LODR)-Updates on AcquisitionDec 11, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On November 30, 2024.Nov 30, 2024
Announcement under Regulation 30 (LODR)-RetirementNov 11, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportNov 11, 2024
Shareholder Meeting / Postal Ballot-Outcome of EGMNov 11, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 06, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptOct 25, 2024
Announcement under Regulation 30 (LODR)-Credit RatingOct 24, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 21, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 21, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 21, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 21, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationOct 20, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 20, 2024

Technical Indicators

RSI(14)
Neutral
65.09
ATR(14)
Volatile
25.77
STOCH(9,6)
Overbought
86.60
STOCH RSI(14)
Overbought
96.09
MACD(12,26)
Bullish
6.91
ADX(14)
Strong Trend
25.15
UO(9)
Bearish
62.36
ROC(12)
Uptrend And Accelerating
12.64
WillR(14)
Overbought
-12.63